Smart Money Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,623
Closed -$1.25M 54
2022
Q1
$1.25M Sell
9,623
-5,793
-38% -$755K 0.84% 26
2021
Q4
$2.35M Buy
15,416
+1,389
+10% +$215K 1.5% 20
2021
Q3
$2.27M Buy
+14,027
New +$2.36M 1.65% 18

Other funds holding IBB

Smart Money Group's IBB Position: Q2 2022 in Review

Smart Money Group sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 9,623 shares — an estimated $1.25M sold.

Smart Money Group first reported a position in IBB in Q3 2021 and held it in 3 quarters. The position peaked at $2.35M in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

  • Smart Money Group reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • Smart Money Group sold 9,623 iShares Biotechnology ETF shares in Q2 2022, an estimated $1.25M.
  • Smart Money Group first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 3 quarters.
  • Smart Money Group's iShares Biotechnology ETF position peaked at $2.35M in Q4 2021.
  • 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Smart Money Group's 13F filing for Q2 2022, filed 14 Jul 2022.